<SEC-DOCUMENT>0001213900-24-101663-index.html : 20241122
<SEC-HEADER>0001213900-24-101663.hdr.sgml : 20241122
<ACCEPTANCE-DATETIME>20241122165815
ACCESSION NUMBER:		0001213900-24-101663
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20241120
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241122
DATE AS OF CHANGE:		20241122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elevai Labs Inc.
		CENTRAL INDEX KEY:			0001840563
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				851399981
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41875
		FILM NUMBER:		241490686

	BUSINESS ADDRESS:	
		STREET 1:		120 NEWPORT CENTER DRIVE
		STREET 2:		STE 250
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		18667944940

	MAIL ADDRESS:	
		STREET 1:		120 NEWPORT CENTER DRIVE
		STREET 2:		STE 250
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Reactive Medical Labs Inc.
		DATE OF NAME CHANGE:	20210114
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0222330-8k_elevai.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea0222330-8k_elevai.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea022233001ex3-1_elevai.htm
<DESCRIPTION>CERTIFICATE OF AMENDMENT FILED ON NOVEMBER 20, 2024
<TEXT>
Document 2 - file: ea022233001ex3-1_elevai.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ea022233001ex99-1_elevai.htm
<DESCRIPTION>PRESS RELEASE DATED AS OF NOVEMBER 22, 2024
<TEXT>
Document 3 - file: ea022233001ex99-1_elevai.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex3-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: ex3-1_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex3-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: ex3-1_002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>elab-20241120.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
Document 6 - file: elab-20241120.xsd

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>elab-20241120_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
Document 7 - file: elab-20241120_lab.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>elab-20241120_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
Document 8 - file: elab-20241120_pre.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 10 - file: R1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 11 - file: Financial_Report.xlsx

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 12 - file: Show.js

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 13 - file: report.css

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 15 - file: FilingSummary.html

Document 15 - RAW XML: FilingSummary.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 17 - file: MetaLinks.json

</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-24-101663-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 18 - file: 0001213900-24-101663-xbrl.zip

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ea0222330-8k_elevai_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 19 - file: ea0222330-8k_elevai_htm.html

Document 19 - RAW XML: ea0222330-8k_elevai_htm.xml

</DOCUMENT>
</SEC-DOCUMENT>